IsoRay Inc ISR:NYSE American

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:58 PM EST
1.06quote price arrow down-0.02 (-1.85%)
Volume
61,724
Close
1.08quote price arrow up+0.05 (+4.85%)
Volume
3,764,526
52 week range
0.35 - 2.81

...

Loading . . .

KEY STATS

  • Open1.01
  • Day High1.12
  • Day Low0.99
  • Prev Close1.03
  • 52 Week High2.81
  • 52 Week High Date01/20/21
  • 52 Week Low0.35
  • 52 Week Low Date11/20/20
  • Market Cap152.50M
  • Shares Out141.20M
  • 10 Day Average Volume9.24M
  • Dividend-
  • Dividend Yield-
  • Beta1.26
  • 1 Year % Change49.34

RATIOS/PROFITABILITY

  • EPS (TTM)-0.05
  • P/E (TTM)-23.43
  • Fwd P/E (NTM)-34.84
  • EBITDA (MRQ)-3.139M
  • ROE (MRQ)-35.14%
  • Revenue (MRQ)9.90M
  • Gross Margin (MRQ)52.41%
  • Net Margin (MRQ)-33.47%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date05/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest IsoRay Inc News

There is no recent news for this security.

Latest ISR News From Our Partners

QUOTE FINDER

Profile

MORE
IsoRay, Inc. is a medical technology company. The Company, through its subsidiary, IsoRay Medical, Inc., develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. The Company is engaged in the production and sales of Cesium-131 (Cs-131) brachytherapy seeds. Brachytherapy seeds are small devices containing a therapeutic dose of radiation used in an interstitial radiation procedure. The brachytherapy...
Michael McCormick
Chairman
Lori Woods
Chief Executive Officer
Jennifer Streeter
Chief Operating Officer
Jonathan Hunt
Chief Financial Officer
Mark Austin
Chief Accounting Officer
Michael Krachon
Executive Vice President
Address
350 Hills St Ste 106
Richland, WA
99354-5511
United States